Have a question or want to speak with a team member?
Stay updated on our progress in changing the landscape of ovarian cancer treatment options and outcomes.

Apr 25, 2022
A Breath of Fresh Hair
Driven by a desire to make a difference in the lives of others affected by this disease, Ann launched a head-shaving fundraiser in Victoria, British Columbia called ‘A Breath of Fresh Hair.’

Jan 11, 2022
The path ahead is bright
CEO Tania Vrionis shares how your donations are put to work immediately. By providing information, supports and building capacity for ovarian cancer research, we are taking Canada by storm. Find out why the path ahead is bright.

Dec 7, 2021
Ovarian Cancer Canada and the Cancer Research Society invest $2.25 million
Ovarian Cancer Canada and the Cancer Research Society invest $2.25 million in ovarian cancer research: Funding for 10 new projects just announced

Highlights from the Fall Symposium
Weeks ago, people from across the country tuned in for Ovarian Cancer Canada’s Fall Symposium. The program featured a wide range of presentations, panel discussions, Q&A sessions, interactive workshops, and networking groups, plus opportunities to unwind with yoga, mind-blowing magic, and more.

USask, Ovarian Cancer Canada, and Province of Saskatchewan team up
A University of Saskatchewan (USask) project will create the province’s only tumour bank and—for the first time in Canada—offer ovarian cancer patients testing to learn if biologic drugs can control their illness.

Aug 17, 2021
Harnessing the power of vaccines to treat ovarian cancer
Most of us have recently heard a great deal about how vaccines help protect against the serious effects of COVID-19. But did you know that vaccines can also be used to treat disease?

Expanding horizons in ovarian cancer research
A new partnership between Ovarian Cancer Canada and the Cancer Research Society recently announced funding for 10 new projects testing treatments that show potential to help people with this disease live longer and better.

Jun 15, 2021
Enabling research on rare forms of ovarian cancer
Dr. Mark Carey is developing scientific models to advance research on low-grade serous cancer, a rare form of the disease.

Apr 6, 2021
IRICoR and Ovarian Cancer Canada announce $2.3M
IRICoR and Ovarian Cancer Canada announce $2.3M for development of new treatments for ovarian cancer